Journal of Clinical Investigation · 2007 · 124 citations · 48 references
Life SciencesCell BiologyMolecular BiologyMolecular Cell BiologyMolecular VirologyVirologyAntiretroviral TherapyAntiviral ImmunityAntiviral ResistanceOncogenic VirusesViral Immune EvasionAntiviral Signaling PathwaysCell Cycle InhibitorsCyclin-dependent Kinase ComplexesCyclin-dependent Kinase RegulationIntegrase ProteinsP21 RegulationPrimitive CellsStem Cell Pool Maintenance
Hematopoietic stem cells are resistant to HIV-1 infection. Here, we report a novel mechanism by which the cyclin-dependent kinase inhibitor (CKI) p21(Waf1/Cip1/Sdi1) (p21), a known regulator of stem cell pool size, restricts HIV-1 infection of primitive hematopoietic cells. Modifying p21 expression altered HIV-1 infection prior to changes in cell cycling and was selective for p21 since silencing the related CKIs, p27(Kip1) and p18(INK4C), had no effect on HIV-1. We show that p21 blocked viral infection by complexing with HIV-1 integrase and aborting chromosomal integration. A closely related lentivirus with a distinct integrase, SIVmac-251, and the other cell-intrinsic inhibitors of HIV-1, Trim5alpha, PML, Murr1, and IFN-alpha, were unaffected by p21. Therefore, p21 is an endogenous cellular component in stem cells that provides a unique molecular barrier to HIV-1 infection and may explain how these cells remain an uninfected "sanctuary" in HIV disease.
48
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
S Waga, Gregory J. Hannon, David Beach et al. · Nature · 1994 · 1.7K citations
New functional activities for the p21 family of CDK inhibitors.
Joshua LaBaer, Michelle D. Garrett, Lauren Stevenson et al. · Genes & Development · 1997 · 1.4K citations · Full text
Hematopoietic Stem Cell Quiescence Maintained by p21 <sup>cip1/waf1</sup>
Tao Cheng, Neil P. Rodrigues, Hongmei Shen et al. · Science · 2000 · 1.3K citations